Ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway

Developmental Biology

Volumn 376, Issue 1, 2013, Pages 74-85

  Rosen, Jonathan N ^a   Sogah, Vanessa M ^a   Ye, Lillian Y ^a   Mably, John D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CCM; Ccm1; Ccm2; Cerebral cavernous malformation; Heg; Zebrafish

Indexed keywords

PLECKSTRIN;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR SYSTEM; CCM1 GENE; CCM2L GENE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EXON; GENE; GENE AMPLIFICATION; GENE DISRUPTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HEART DEVELOPMENT; HEG CCM SIGNALING PATHWAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRON; LOSS OF FUNCTION MUTATION; MOLECULAR CLONING; MORPHOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; NOTOCHORD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RESTRICTION SITE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; ZEBRA FISH;

DANIO RERIO;

EID: 84875248291     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2013.01.006     Document Type: Article

References (38)

1. Bergametti F., Denier C., Labauge P., Arnoult M., Boetto S., Clanet M., Coubes P., Echenne B., Ibrahim R., Irthum B., Jacquet G., Lonjon M., Moreau J.J., Neau J.P., Parker F., Tremoulet M., Tournier-Lasserve E Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 2005, 76:42-51.
2. Boulday G., Blecon A., Petit N., Chareyre F., Garcia L.A., Niwa-Kawakita M., Giovannini M., Tournier-Lasserve E. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model Mech. 2009, 2:168-177.
3. Burns C.G., MacRae C.A. Purification of hearts from zebrafish embryos. Biotechniques 40 2006, 274(276):278. passim.
4. Crose L.E., Hilder T.L., Sciaky N., Johnson G.L. Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J. Biol. Chem. 2009, 284:13301-13305.
5. de Pater E., Clijsters L., Marques S.R., Lin Y.F., Garavito-Aguilar Z.V., Yelon D., Bakkers J. Distinct phases of cardiomyocyte differentiation regulate growth of the zebrafish heart. Development (Cambridge, England) 2009, 136:1633-1641.
6. Denier C., Goutagny S., Labauge P., Krivosic V., Arnoult M., Cousin A., Benabid A.L., Comoy J., Frerebeau P., Gilbert B., Houtteville J.P., Jan M., Lapierre F., Loiseau H., Menei P., Mercier P., Moreau J.J., Nivelon-Chevallier A., Parker F., Redondo A.M., Scarabin J.M., Tremoulet M., Zerah M., Maciazek J., Tournier-Lasserve E. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 2004, 74:326-337.
7. Denier C., Labauge P., Bergametti F., Marchelli F., Riant F., Arnoult M., Maciazek J., Vicaut E., Brunereau L., Tournier-Lasserve E. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 2006, 60:550-556.
8. Gingras A.R., Liu J.J., Ginsberg M.H. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. J. Cell Biol. 199 2012, 39-48.
9. Glading A., Han J., Stockton R.A., Ginsberg M.H. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 179 2007, 247-254.
10. Gough J., Karplus K., Hughey R., Chothia C. Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. J. Mol. Biol. 2001, 313:903-919.
11. Hilder T.L., Malone M.H., Bencharit S., Colicelli J., Haystead T.A., Johnson G.L., Wu C.C., Proteomic identification of the cerebral cavernous malformation signaling complex. J. Proteome Res 2007, 6:4343-4355.
12. Hogan B.M., Bussmann J., Wolburg H., Schulte-Merker S. ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 2008, 17:2424-2432.
13. Kim J., Sherman N.E., Fox J.W., Ginsberg M.H. Phosphorylation sites in the cerebral cavernous malformations complex. J. Cell Sci. 2011, 124:3929-3932.
14. Kleaveland B., Zheng X., Liu J.J., Blum Y., Tung J.J., Zou Z., Sweeney S.M., Chen M., Guo L., Lu M.M., Zhou D., Kitajewski J., Affolter M., Ginsberg M.H., Kahn M.L. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 2009, 15:169-176.
15. Laberge-le Couteulx S., Jung H.H., Labauge P., Houtteville J.P., Lescoat C., Cecillon M., Marechal E., Joutel A., Bach J.F., Tournier-Lasserve E. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 1999, 23:189-193.
16. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002, 248:307-318.
17. Li X., Zhang R., Zhang H., He Y., Ji W., Min W., Boggon T.J. Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity. J. Biol. Chem. 2010, 285:24099-24107.
18. Liquori C.L., Berg M.J., Siegel A.M., Huang E., Zawistowski J.S., Stoffer T., Verlaan D., Balogun F., Hughes L., Leedom T.P., Plummer N.W., Cannella M., Maglione V., Squitieri F., Johnson E.W., Rouleau G.A., Ptacek L., Marchuk D.A. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 2003, 73:1459-1464.
19. Liu J., Bressan M., Hassel D., Huisken J., Staudt D., Kikuchi K., Poss K.D., Mikawa T., Stainier D.Y. A dual role for ErbB2 signaling in cardiac trabeculation. Development (Cambridge, England) 2010, 137:3867-3875.
20. Liu J.J., Stockton R.A., Gingras A.R., Ablooglu A.J., Han J., Bobkov A.A., Ginsberg M.H. A mechanism of Rap1-induced stabilization of endothelial cell--cell junctions. Mol. Biol. Cell 2011, 22:2509-2519.
21. Mably J.D., Childs S.J. Developmental Physiology of the Zebrafish Cardiovascular System. Zebrafish: Fish Physiology 2010, 249-287. Academic Press, London. First ed. S.F. Perry, M. Ekker, A.P. Farrell, C.J. Brauner (Eds.).
22. Mably J.D., Chuang L.P., Serluca F.C., Mohideen M.A., Chen J.N., Fishman M.C. santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development (Cambridge, England) 2006, 133:3139-3146.
23. Mably J.D., Mohideen M.A., Burns C.G., Chen J.N., Fishman M.C. heart of glass regulates the concentric growth of the heart in zebrafish. Curr. Biol. 2003, 13:2138-2147.
24. Mariappan D., Niemann R., Gajewski M., Winkler J., Chen S., Choorapoikayil S., Bitzer M., Schulz H., Hescheler J., Sachinidis A. Somitovasculin, a novel endothelial-specific transcript involved in the vasculature development. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1823-1829.
25. Revencu N., Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J. Med. Genet. 2006, 43:716-721.
26. Sahoo T., Johnson E.W., Thomas J.W., Kuehl P.M., Jones T.L., Dokken C.G., Touchman J.W., Gallione C.J., Lee-Lin S.Q., Kosofsky B., Kurth J.H., Louis D.N., Mettler G., Morrison L., Gil-Nagel A., Rich S.S., Zabramski J.M., Boguski M.S., Green E.D., Marchuk D.A. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 1999, 8:2325-2333.
27. Schottenfeld J., Sullivan-Brown J., Burdine R.D. Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-specific expression of southpaw. Development (Cambridge, England) 2007, 134:1605-1615.
28. Stockton R.A., Shenkar R., Awad I.A., Ginsberg M.H. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 2010, 207:881-896.
29. Voss K., Stahl S., Hogan B.M., Reinders J., Schleider E., Schulte-Merker S., Felbor U. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum. Mutat. 2009, 30:1003-1011.
30. Voss K., Stahl S., Schleider E., Ullrich S., Nickel J., Mueller T.D., Felbor U. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 2007, 8:249-256.
31. Whitehead K.J., Chan A.C., Navankasattusas S., Koh W., London N.R., Ling J., Mayo A.H., Drakos S.G., Jones C.A., Zhu W., Marchuk D.A., Davis G.E., Li D.Y. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 2009, 15:177-184.
32. Whitehead K.J., Plummer N.W., Adams J.A., Marchuk D.A., Li D.Y. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development (Cambridge, England) 2004, 131:1437-1448.
33. Wong J.H., Awad I.A., Kim J.H. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 2000, 46:1454-1459.
34. Yoruk B., Gillers B.S., Chi N.C., Scott I.C. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease. Dev. Biol. 2012, 362:121-131.
35. Zawistowski J.S., Stalheim L., Uhlik M.T., Abell A.N., Ancrile B.B., Johnson G.L., Marchuk D.A. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 2005, 14:2521-2531.
36. Zhang J., Rigamonti D., Dietz H.C., Clatterbuck R.E. Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery 2007, 60:353-359. discussion 359.
37. Zheng X., Xu C., Di Lorenzo A., Kleaveland B., Zou Z., Seiler C., Chen M., Cheng L., Xiao J., He J., Pack M.A., Sessa W.C., Kahn M.L. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J. Clin. Invest. 2010, 120:2795-2804.
38. Zheng X., Xu C., Smith A.O., Stratman A.N., Zou Z., Kleaveland B., Yuan L., Didiku C., Sen A., Liu X., Skuli N., Zaslavsky A., Chen M., Cheng L., Davis G.E., Kahn M.L. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. Dev. Cell 2012, 23:342-355.